Podcast
Questions and Answers
Which approach is a modification of adoptive T cell therapy that uses viral vectors to express a chimeric antigen receptor (CAR)?
Which approach is a modification of adoptive T cell therapy that uses viral vectors to express a chimeric antigen receptor (CAR)?
- Adoptive therapy with autologous tumor-specific T cells
- Enhancing antitumor immunity
- Chimeric antigen receptor (CAR) expressing T cells (correct)
- Activating T cells ex vivo
What is the likely reason for inconsistent results of adoptive T cell therapy with autologous tumor-specific T cells?
What is the likely reason for inconsistent results of adoptive T cell therapy with autologous tumor-specific T cells?
- Low frequency of tumor-specific T cells (correct)
- Lack of T cell-stimulating cytokines
- Insufficient expansion of T cell population
- Ineffective migration of activated CTLs into the tumor
What is the function of chimeric antigen receptor (CAR) in CAR-expressing T cells?
What is the function of chimeric antigen receptor (CAR) in CAR-expressing T cells?
- Isolates T cells from the blood or tumor biopsies
- Stimulates the production of growth factors
- Recognizes tumor antigens and destroys them
- Activates the T cells and enhances their proliferation (correct)
Which of the following is true about CAR-T cell therapy?
Which of the following is true about CAR-T cell therapy?
What is the main function of the intracellular signaling domains in CAR-T cells?
What is the main function of the intracellular signaling domains in CAR-T cells?
What is the most serious toxicity associated with CAR-T cell therapy?
What is the most serious toxicity associated with CAR-T cell therapy?
Why has CAR-T cell therapy not been successful in solid tumors?
Why has CAR-T cell therapy not been successful in solid tumors?
Flashcards are hidden until you start studying
Study Notes
Adoption of CAR-T Cell Therapy
- Viral Vectors and CAR: The approach involves using viral vectors to express a chimeric antigen receptor (CAR), enhancing the effectiveness of adoptive T cell therapy.
Inconsistencies in Autologous T Cell Responses
- Variability in Responses: Inconsistent results with autologous tumor-specific T cells are often due to factors like tumor heterogeneity and T cell dysfunction within the tumor microenvironment.
Role of Chimeric Antigen Receptor (CAR)
- Targeting Mechanism: CARs on T cells enable the recognition of specific antigens presented by cancer cells, enhancing the targeted attack against tumors.
CAR-T Cell Therapy Insights
- General Outcome: CAR-T cell therapy has shown effective results in hematological malignancies but faces challenges in solid tumors.
Function of Intracellular Signaling Domains
- Activation and Proliferation: The intracellular signaling domains in CAR-T cells are crucial for activating T cells, promoting their proliferation, and instructing them to kill targeted cancer cells.
Serious Toxicity Concerns
- Cytokine Release Syndrome: The most serious toxicity associated with CAR-T cell therapy is cytokine release syndrome (CRS), which can lead to severe complications if not managed promptly.
Challenges in Solid Tumor Therapy
- Obstacles in Efficacy: The limited success of CAR-T cell therapy in solid tumors is attributed to factors like the lack of suitable tumor-specific antigens, immunosuppressive tumor microenvironments, and physical barriers surrounding the tumors.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
